KALA BIO, Inc. — Form 10-Q
Filed August 19, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Avi Minkowitz, serving as both Principal Executive Officer and Principal Financial Officer, certified on August 19, 2026 that the Q2 2026 10-Q (period ended June 30, 2026) complies with SEC requirements and fairly presents the company's financial condition and results. Standard Sarbanes-Oxley certifications (Sections 302 and 906) with attestations to disclosure controls, internal controls over financial reporting, and absence of material misstatements or fraud. No specific financial data, transactions, or operational changes are disclosed in these certification exhibits.
Why this rating
Pure procedural certification; no operational or financial developments disclosed. Routine quarterly compliance filing, material only if undisclosed control deficiencies existed.
See more from August 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.